结核后肺部疾病患者的肺部康复:一个前性的多中心研究
Denise Rossato Silva1, Fernanda Carvalho de Queiroz Mello2, Tatiana Senna Galvão3
1Faculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
Archivos de bronconeumologia
|March 7, 2025
概括
肺部康复 (PR) 在结核后肺部疾病 (PTLD) 患者中显著改善肺功能和运动能力. 这项多中心研究强调了PR计划对PTLD恢复的好处.
科学领域:
- 肺部病理学 肺部病理学
- 康复医学 康复医学 康复医学
- 公共卫生 公共卫生
背景情况:
- 以前对肺复原治疗肺结核后肺病 (PTLD) 的研究往往缺乏大样本大小和全面的功能评估.
- 需要多中心研究来验证在不同环境中在PTLD中PR的好处.
研究的目的:
- 评估综合性肺部康复计划 (PRP) 对肺结核后肺病 (PTLD) 患者的好处.
- 为了比较经过PR的PTLD患者与没有接受康复治疗的患者的功能结果.
主要方法:
- 一组1 (n=85) PTLD患者接受了为期5周的综合性PRP治疗.
- 第二组 (n=96) PTLD患者作为非康复的对照组.
- 功能性评估包括肺功能测试,6分钟步行测试 (6MWT) 和动脉血液气体分析在PRP之前和之后进行,对1组,在基线和2组3个月后进行.
主要成果:
- 第1组在1秒内强迫呼气量 (FEV1),强迫生命能力 (FVC),肺部对一氧化碳的扩散能力 (DLCO),6MWT距离和氧和度 (SaO2) 显著改善.
- 相反,第二组在3个月的随访期间,几个功能参数下降.
- 该研究表明,在PTLD患者中,可归因于PRP的统计学上显著的功能收益.
结论:
- 肺部康复计划为PTLD患者提供了显著的好处,提高了肺功能和运动能力.
- 应将可访问和高质量的治疗后PR纳入国家结核病计划,以支持PTLD患者的康复.
- 这些发现支持广泛实施PTLD患者的PR,以改善长期结果.
相关概念视频
01:28Pulmonary Tuberculosis V
162
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
162
01:28Pulmonary Tuberculosis II
207
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
207
01:29Pulmonary Tuberculosis I
215
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
215
01:26Pulmonary Tuberculosis IV
127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
01:25Pulmonary Function Tests
285
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
285
01:27Pneumothorax-II
112
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
112